Integrating Touchscreen-based Geriatric Assessment and Frailty Screening for Adults With Multiple Myeloma
NCT03068637 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 165
Last updated 2018-06-15
Summary
The overarching objective of this study is to evaluate the feasibility, usability, and acceptability of an abbreviated, tablet-based geriatric assessment in a population of older adults with multiple myeloma.
Conditions
Interventions
- BEHAVIORAL
-
Carevive CPS
This intervention will focus on the use of the Carevive CPS at the point of care to enable providers to deliver evidence-based and personalized supportive care and symptom management plans to their MM patients receiving active treatment. The Carevive CPS collects electronic patient reported outcomes (ePROs) and clinical data, reported and entered by clinical staff and/or extracted from the electronic medical record (EMR), and uses these to auto-generate the personalized care plans. Care plan content is driven by practice guidelines and other peer-reviewed evidence, and includes patient education, resources, and referrals developed by expert cancer clinicians and researchers.
Sponsors & Collaborators
-
Carevive Systems, Inc.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-08-23
- Primary Completion
- 2017-11-08
- Completion
- 2018-04-01
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
NCT00242827 ·Status: TERMINATED ·Phase: PHASE2
-
Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
NCT00002850 ·Status: COMPLETED ·Phase: PHASE3
-
Intervention for Symptom Burden During Maintenance Therapy for Multiple Myeloma
NCT01793051 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
NCT00899080 ·Status: COMPLETED
-
Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
NCT00099047 ·Status: COMPLETED ·Phase: PHASE2
-
The Ambient Light Multiple Myeloma Study
NCT05737732 ·Status: RECRUITING ·Phase: NA
-
Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire
NCT05817331 ·Status: COMPLETED
-
Efficacy of NF-kB Inhibition for Reducing Symptoms During Maintenance Therapy in Multiple Myeloma Patients
NCT01269203 ·Status: WITHDRAWN ·Phase: PHASE2
-
Examination of Trends in Multiple Myeloma Trial Patient Experiences
NCT05860179 ·Status: NOT_YET_RECRUITING
-
A Randomized, Phase I, Cross-Over Study to Assess the Relative Bioavailability of Single-Dose Cobimetinib (GDC-0973) in Tablet vs. Capsule Formulation
NCT02136524 ·Status: COMPLETED ·Phase: PHASE1
-
MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey
NCT04727294 ·Status: UNKNOWN
-
Efficacy and Safety of Statin on the Course of Progressive Smoldering Multiple Myeloma
NCT00503763 ·Status: WITHDRAWN ·Phase: PHASE2
-
Strength Training in Improving Pain and Quality of Life in Patients With Multiple Myeloma
NCT03793907 ·Status: COMPLETED ·Phase: NA
-
Correlative Biomarker Study in Patients With Myeloproliferative Disorders
NCT00665067 ·Status: COMPLETED
-
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
NCT01099267 ·Status: COMPLETED
-
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
NCT00809575 ·Status: UNKNOWN
-
Prevention of Treatment Induced Neuropathy in Multiple Myeloma
NCT01283997 ·Status: COMPLETED ·Phase: PHASE2
-
Treating Cancer-Related Fatigue Through Systematic Light Exposure (Light for Fatigue Study)
NCT03119363 ·Status: COMPLETED ·Phase: NA
-
Mychoice: Testing an Interactive mHealth Tool
NCT03427177 ·Status: COMPLETED ·Phase: NA
-
Curcumin (Diferuloylmethane Derivative) With or Without Bioperine in Patients With Multiple Myeloma
NCT00113841 ·Status: COMPLETED ·Phase: NA
-
CC-4047 in Treating Patients With Myelofibrosis
NCT00669578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma
NCT00942422 ·Status: TERMINATED ·Phase: PHASE2
-
Autoimmunity After Checkpoint Blockade
NCT04119713 ·Status: RECRUITING
-
MMRF CureCloud Research Initiative
NCT03657251 ·Status: TERMINATED
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
NCT06055894 ·Status: RECRUITING ·Phase: NA